tiprankstipranks
SAB Biotherapeutics provides SAB-142 clinical trial progress update
PremiumThe FlySAB Biotherapeutics provides SAB-142 clinical trial progress update
5M ago
SAB Biotherapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
SAB Biotherapeutics initiated with an Outperform at Oppenheimer
5M ago
SAB Biotherapeutics founds Clinical Advisory Board for SAB-142 development
Premium
The Fly
SAB Biotherapeutics founds Clinical Advisory Board for SAB-142 development
6M ago
SAB Biotherapeutics initiated with Buy on risk/reward at Brookline
PremiumThe FlySAB Biotherapeutics initiated with Buy on risk/reward at Brookline
8M ago
SAB Biotherapeutics initiated with a Buy at Brookline
Premium
The Fly
SAB Biotherapeutics initiated with a Buy at Brookline
8M ago
SAB Biotherapeutics Appoints Mr. Conley, Details Public Disclosure
Premium
Company Announcements
SAB Biotherapeutics Appoints Mr. Conley, Details Public Disclosure
8M ago
SAB Biotherapeutics Advances SAB-142 in Phase One Trials
PremiumCompany AnnouncementsSAB Biotherapeutics Advances SAB-142 in Phase One Trials
10M ago
SAB Biotherapeutics price target lowered to $6 from $10 at H.C. Wainwright
Premium
The Fly
SAB Biotherapeutics price target lowered to $6 from $10 at H.C. Wainwright
10M ago
SABS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SABS Earnings this Week: How Will it Perform?
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100